These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33902699)

  • 1. Systematic review of the use of translated patient-reported outcome measures in cancer trials.
    Slade AL; Retzer A; Ahmed K; Kyte D; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Turner G; Calvert MJ
    Trials; 2021 Apr; 22(1):306. PubMed ID: 33902699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Orthopaedic Clinical Trials Linguistically and Culturally Diverse? A Systematic Review.
    Julian KR; Mulakaluri A; Truong NM; Fernandez A; Kamal RN; Shapiro LM
    JBJS Rev; 2024 May; 12(5):. PubMed ID: 39021638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative study.
    Retzer A; Calvert M; Ahmed K; Keeley T; Armes J; Brown JM; Calman L; Gavin A; Glaser AW; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Efficace F; Mercieca-Bebber R; King MT; Kyte D
    Cancer Med; 2021 Aug; 10(16):5475-5487. PubMed ID: 34219395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current practices in patient-reported outcome (PRO) data collection in clinical trials: a cross-sectional survey of UK trial staff and management.
    Kyte D; Ives J; Draper H; Calvert M
    BMJ Open; 2016 Oct; 6(10):e012281. PubMed ID: 27697875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine head and neck cancer care: What do health professionals perceive as barriers and facilitators?
    Nguyen H; Butow P; Dhillon H; Morris L; Brown A; West K; Sundaresan P
    J Med Imaging Radiat Oncol; 2020 Oct; 64(5):704-710. PubMed ID: 32394587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are Clinical Practice Guidelines Representative of Patients With Distal Radius Fractures? A Review of Patient Demographics and Patient-Reported Outcome Measures Used to Inform Guidelines.
    Mulakaluri A; Julian KR; Fernandez A; Kamal RN; Shapiro LM
    J Hand Surg Am; 2024 Jul; 49(7):649-655. PubMed ID: 38739072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis.
    Rivera SC; Kyte DG; Aiyegbusi OL; Slade AL; McMullan C; Calvert MJ
    Health Qual Life Outcomes; 2019 Oct; 17(1):156. PubMed ID: 31619266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which patient reported outcomes (PROs) and patient reported outcome measures (PROMs) do researchers select in stress urinary incontinence surgical trials? - a systematic review.
    Loganathan J; Coffey J; Doumouchtsis SK;
    Int Urogynecol J; 2022 Nov; 33(11):2941-2949. PubMed ID: 35254471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the barriers to using Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs) in routine cancer care.
    Nguyen H; Butow P; Dhillon H; Sundaresan P
    J Med Radiat Sci; 2021 Jun; 68(2):186-195. PubMed ID: 32815314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis.
    Vanderhout S; Fergusson DA; Cook JA; Taljaard M
    PLoS Med; 2022 Feb; 19(2):e1003896. PubMed ID: 35134080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol.
    Retzer A; Keeley T; Ahmed K; Armes J; Brown JM; Calman L; Copland C; Efficace F; Gavin A; Glaser A; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Mercieca-Bebber R; King MT; Calvert M; Kyte D
    BMJ Open; 2018 Feb; 8(2):e017282. PubMed ID: 29431123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence.
    Nic Giolla Easpaig B; Tran Y; Bierbaum M; Arnolda G; Delaney GP; Liauw W; Ward RL; Olver I; Currow D; Girgis A; Durcinoska I; Braithwaite J
    BMC Health Serv Res; 2020 Feb; 20(1):102. PubMed ID: 32041593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core Patient-Reported Outcomes (PROs) and PRO Measures (PROMs) for Polypharmacy Medicines Reviews: A Sequential Mixed-Methods Study.
    Kotronoulas G; Cooper M; Johnston B
    Patient Prefer Adherence; 2019; 13():2071-2087. PubMed ID: 31853173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Person-reported outcomes in registered randomised diabetes trials: A mapping review of constructs.
    de Wit M; van Luik S; Marrero D; Barnard-Kelly K; Snoek FJ
    Diabet Med; 2024 Sep; 41(9):e15385. PubMed ID: 38874332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation.
    Lidington E; Hogan H; Gandolfi A; Lawrence J; Younger E; Cho H; Peckitt C; Mohammed K; Matharu S; Scerri L; Husson O; Cruickshank S; Turner R; Wedlake L
    J Patient Rep Outcomes; 2022 Dec; 6(1):128. PubMed ID: 36547735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review.
    Rutherford C; Patel MI; Tait MA; Smith DP; Costa DSJ; King MT
    Support Care Cancer; 2018 Apr; 26(4):1061-1076. PubMed ID: 29392479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating a tool to improve engagement and recruitment of under-served groups in trials.
    Morris L; Dumville J; Treweek S; Miah N; Curtis F; Bower P
    Trials; 2022 Oct; 23(1):867. PubMed ID: 36210444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.